This multicentric retrospective study has assessed the natural growth rate of HCC in patients with available with 2 contrast-enhanced imaging performed more than 30 days apart prior to HCC treatment. The median tumor doubling time was 290 days and 38% of HCC was considered as indolent (tumor doubling time > 365 days) whereas 22.5% was considered to have an aggressive pattern (tumor doubling time < 90 days).

(Rich NE et al. – NCBI, February 2020)

Read more